Goldman Sachs Group Inc Opgen Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 14, 2024
BUY
$0.12 - $62.0 $2,476 - $1.28 Million
20,638 New
20,638 $2,000
Q4 2022

Feb 13, 2023
BUY
$0.12 - $62.0 $2,476 - $1.28 Million
20,638 New
20,638 $2,000

Others Institutions Holding OPGN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About OPGEN INC

OPGN Quotes by TradingView
  • Ticker OPGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,698,500
  • Market Cap $38.7M
  • Description
  • OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...
More about OPGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email